Get in Touch
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.
As a dynamic independently held clinical research site company, ERG offers a deep bench of specialized expertise in more than 50 specific indications, with unparalleled capabilities in CNS studies.
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors speed life-saving and life-enhancing therapeutics to market as quickly and safely as possible.
Chief Executive Officer
President
Chief Medical Officer
Chief Scientific Officer
Chief Information Officer
Chief of Staff
Executive Vice President, Strategic Initiatives
Executive Vice President, Strategic Operations
Vice President, Business Development
Executive Vice President, Business Operations & Finance
%20(1).png)
Senior Vice President, Contracts and Budgets
Vice President, Quality Assurance
CFO
With access to over 32 million patients/subjects and 5000+ completed trials, ERG continues to grow its capabilities and expand into indications where there are tremendous unmet medical needs in the United States and globally.
Unparalleled support for sponsors and CROs in their quest to address our nation’s greatest unmet medical needs.
Learn MoreWe strive to be active participants, using the power of collective effort to accelerate new therapeutic options for those who need them so desperately. Here are a few of our partnerships.
The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
ACNP is a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.
The American Society of Clinical Psychopharmacology (ASCP) was founded in 1992 to advance the science and practice of clinical psychopharmacology. Its over 900 members are physicians who study and practice psychopharmacology, as well as doctoral level investigators of clinical psychopharmacology or of pharmacology. ASCP members are advocates for clinical psychopharmacology and for clinical research.
Founded in 1994, AMR Clinical is a leading clinical research organization consisting of fully-owned and affiliate research centers across the U.S. With 32 locations, AMR has conducted more than 7,700 clinical trials and enrolled over 145,000 participants. Specializing in Phase I-IV clinical trials, AMR offers expertise in various therapeutic areas such as cardiology, dermatology, endocrinology, vaccines, and more. AMR’s success is built on strong relationships with sponsors, CROs, and healthcare providers, delivering high-quality data and consistent patient recruitment to accelerate drug development.
ERG is a founding patron of the CNS Summit. This community of leaders from pharmaceutical and biotech companies, innovative technology companies, startups, patient advocates, investigator sites, service companies, regulators and investors is driven to accelerate the success of programs that bring novel treatments to patients.
The Foundation for the National Institutes of Health (FNIH) creates and leads alliances and public-private partnerships that advance breakthrough biomedical discoveries and improve the quality of people’s lives. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization that convenes public and private partnerships between the NIH, academia, life science companies, and patient advocacy groups.
The Global Alzheimer’s Platform Foundation (GAP) focuses on reducing the time and cost of Alzheimer’s disease (AD) clinical research trials in order to speed innovative therapies to those who need them. GAP-Net is a key initiative; this network of more than 60 leading academic and private clinical research sites across the United States and Canada fast-tracks patient recruitment and optimizes site operations, accelerating trial start-up. ERG is proud to be part of this network.
Fueled by passion and urgency, National Kidney Foundation is a lifeline for all people affected by kidney disease. As pioneers of scientific research and innovation, NKF focuses on the whole patient through the lens of kidney health. Relentless in our work, we enhance lives through action, education and accelerating change.
The Society for Clinical Research Sites (SCRS) was founded in 2012 to represent clinical research sites globally, providing a unified voice and a community dedicated to greater site sustainability. SCRS currently represents over 9,500 research sites in 47 countries, serving as an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.
The International Society for CNS Clinical Trials and Methodology (ISCTM) is an independent multi-disciplinary organization devoted to promoting advances in, and dissemination of, clinical research methods related to development and use of CNS therapeutics. The ISCTM accomplishes this by bringing together international stakeholders representing academia, industry, government, payers, policymakers, and the public to address strategic clinical, regulatory, methodological and policy challenges in clinical research.
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.
